{"Clinical Trial ID": "NCT01302379", "Intervention": ["INTERVENTION 1:", "Metformin + lifestyle intervention", "Week 1: 500 mg at dinner time Weeks 2-4: 1000 mg at dinner time Weeks 5+: 500 mg in the morning; 1000 mg at dinner time", "A lifestyle intervention: a lifestyle intervention based on the phone (food change and physical activity) for weight loss.", "INTERVENTION 2:", "Placebo + lifestyle intervention", "Placebo: Week 1: 1 pill at dinner time Weeks 2-4: 2 pills at dinner time Weeks 5+: 1 pill in the morning; 2 pills at dinner time", "A lifestyle intervention: a lifestyle intervention based on the phone (food change and physical activity) for weight loss."], "Eligibility": ["Incorporation criteria:", "At least 25.0 kg/m2 BMI", "Stage I, II or III breast cancer diagnosis in the last 5 years", "Treatment by total mastectomy or surgical elimination of breast dispersal from cancer with clear macroscopic margins, and axillary dissection, followed by adjuvant breast radiation", "No chemotherapy planned or in the course of chemotherapy", "\u2022 Accessible geographically and by telephone", "\u2022 Capable of communicating food and physical activity data by telephone", "In case of taking statins, tamoxifen or aromatase inhibitors; capable and ready to remain in treatment for a 6-month study period", "Postmenopausal diagnosis", "- Exclusion criteria:", "A preliminary blood test outside the specified forks", "Evidence of renal failure, hepatic failure or congestive heart failure", "Currently taking corticosteroid pills or steroid hormone therapy (including vaginal estrogen creams)", "Recent initiation (less than 3 months ago) of thiazides or blockers \u03b2", "Insulin or other antidiabetic medicinal product", "Other primary or recurrent invasive cancers in the last 10 years", "Unable to engage in study requirements"], "Results": ["Performance measures:", "Insulin", "Insulin measured as a percentage change from baseline", "Time limit: change from the reference period to the 6-month period", "Results 1:", "Title of the arm/group: Metformin + lifestyle intervention", "Description of the arm/group: Metformin: Week 1: 500 mg at dinner time Weeks 2-4: 1000 mg at dinner time Weeks 5+: 500 mg in the morning; 1000 mg at dinner time", "A lifestyle intervention: a lifestyle intervention based on the phone (food change and physical activity) for weight loss.", "Total number of participants analysed: 83", "Average least squares (95% confidence interval)", "Unit of measure: percentage change from baseline -21.8 (-29.7 to -13.0)", "Results 2:", "Title of the arm/group: Placebo + lifestyle intervention", "Description of the arm/group: Placebo: Week 1: 1 pill at dinner time Weeks 2-4: 2 pills at dinner time Weeks 5+: 1 pill in the morning; 2 pills at dinner time", "A lifestyle intervention: a lifestyle intervention based on the phone (food change and physical activity) for weight loss.", "Total number of participants analysed: 83", "Average least squares (95% confidence interval)", "Unit of measure: percentage change from reference value -17.7 (-25.9 to -8.6)"], "Adverse Events": ["Undesirable Events 1:", "Total: 5/333 (1.50 per cent)", "1/333 (0.30%)", "Injury due to fall1/333 (0.30%)", "Abdominal pain1/333 (0.30%)", "1/333 (0.30%)", "Adverse Events 2:", "Total: 5/333 (1.50 per cent)", "1/333 (0.30%)", "Injury due to fall1/333 (0.30%)", "Abdominal pain1/333 (0.30%)", "1/333 (0.30%)"]}